Skip Navigation

This Article
Right arrow Print PDF (663K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Brent, T.P.
Right arrow Articles by Remack, J.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brent, T.P.
Right arrow Articles by Remack, J.S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1988, Vol. 16, No. 14 6779-6788
© 1988

Articles

Formation of covalent complexes between human O6 alkyltransferase and BCNU-treated defined length synthetic oligodeoxynucleotides

T.P. Brent and J.S. Remack

Department of Biochemical and Clinical Pharmacology St Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38101, USA

Received April 26, 1988. Revised June 10, 1988. Accepted June 10, 1988.

Repair of chloroethylnitrosourea (CENU)-induced precursors of DNA interstrand cross-links by O6-alkyltransferase (GAT or GATase) appears to be a factor in tumor resistance to therapy with this class of antineoplastic drugs. Since human GAT is highly specific for O6 -guanine, yet the probable cross-link structure is N'-Guanine N3 cytosine ethane, rearrangement of the initial O6 -guanine adduct via O6, N1ethanoguanine has been proposed. We suggested that GAT reaction with this intermediate would produce DNA covalently linked to protein through an ethane link from N1 -guanine to the alkylacceptor site on GAT. In preliminary studies we demonstrated a covalent complex between GAT and carmustine (BCNU)-treated DNA by a precipitation assay method. We have now developed a method for isolating the reaction product of BCNU-treated synthetic 14-mer [ 32p] - labeled oligodeoxynucleotide and GAT using polyacrylamide gel electro phoresis. This approach can be used to characterize the adducts induced by CENUs that lead to complex formation with CAT. Results obtained to date are consistent with these adducts being precursors of DNA interstrand cross-links.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
R. J. Hansen, R. Nagasubramanian, S. M. Delaney, L. D. Samson, and M.E. Dolan
Role of O6-methylguanine-DNA methyltransferase in protecting from alkylating agent-induced toxicity and mutations in mice
Carcinogenesis, May 1, 2007; 28(5): 1111 - 1116.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. J. Hansen, R. Nagasubramanian, S. M. Delaney, M. M. Cherian, S. Lin, S. C. Kogan, and M. E. Dolan
Role of O6-Alkylguanine-DNA Alkyltransferase in Protecting against 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-Induced Long-Term Toxicities
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1247 - 1255.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
D. M. Noll and N. D. Clarke
Covalent capture of a human O6-alkylguanine alkyltransferase-DNA complex using N1,O6-ethanoxanthosine, a mechanism-based crosslinker
Nucleic Acids Res., October 1, 2001; 29(19): 4025 - 4034.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
E. L. Kreklau, C. Kurpad, D. A. Williams, and L. C. Erickson
Prolonged Inhibition of O6-Methylguanine DNA Methyltransferase in Human Tumor Cells by O6-Benzylguanine In Vitro and In Vivo
J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1269 - 1275.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
P. L. Fischhaber, A. S. Gall, J. A. Duncan, and P. B. Hopkins
Direct Demonstration in Synthetic Oligonucleotides that N,N'-Bis(2-chloroethyl)-nitrosourea Cross-Links N1 of Deoxyguanosine to N3 of Deoxycytidine on Opposite Strands of Duplex DNA
Cancer Res., September 1, 1999; 59(17): 4363 - 4368.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
B. J. Glassner, G. Weeda, J. M. Allan, J. L.M. Broekhof, N. H.E. Carls, I. Donker, B. P. Engelward, R. J. Hampson, R. Hersmus, M. J. Hickman, et al.
DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents
Mutagenesis, May 1, 1999; 14(3): 339 - 347.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. P. Spiro, S. L. Gerson, L. Liu, S. Majka, J. Haaga, C. L. Hoppel, S. T. Ingalls, J. M. Pluda, and J. K. V. Willson
O6-Benzylguanine: A Clinical Trial Establishing the Biochemical Modulatory Dose in Tumor Tissue for Alkyltransferase-directed DNA Repair
Cancer Res., May 1, 1999; 59(10): 2402 - 2410.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.